Genetic Variants Associated with Colorectal Adenoma Susceptibility

• Anna Abulí,

  Affiliation Department of Gastroenterology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Pompeu Fabra University, Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
• Antoni Castells,

  Affiliation Department of Gastroenterology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Catalonia, Spain

  ⨯
• Luis Bujanda,

  Affiliation Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad del País Vasco (UPV/EHU), Doctor Begiristain Kalea, 20014, Donostia/Gipuzkoa, Spain

  ⨯
• Juan José Lozano,

  Affiliation Plataforma de Bioinformática, CIBERehd, Villarroel 170, 08036, Barcelona, Catalonia, Spain

  ⨯
• Xavier Bessa,

  Affiliation Department of Gastroenterology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Pompeu Fabra University, Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
• Cristina Hernández,

  Affiliation Department of Epidemiology and Evaluation, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
• Cristina Álvarez-Urturi,

  Affiliation Department of Gastroenterology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Pompeu Fabra University, Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
• Maria Pellisé,

  Affiliation Department of Gastroenterology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Catalonia, Spain

  ⨯
• Clara Esteban-Jurado,

  Affiliation Department of Gastroenterology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Catalonia, Spain

  ⨯
• Elizabeth Hijona,

  Affiliation Department of Gastroenterology, Hospital Donostia/Instituto Biodonostia, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad del País Vasco (UPV/EHU), Doctor Begiristain Kalea, 20014, Donostia/Gipuzkoa, Spain

  ⨯
• Andrea Burón,

  Affiliation Department of Epidemiology and Evaluation, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
• Francesc Macià,

  Affiliation Department of Epidemiology and Evaluation, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
• Jaume Grau,

  Affiliation Unitat d’Avaluació, Suport i Preventiva, Hospital Clínic, Roselló 138, 08036, Barcelona, Catalonia, Spain

  ⨯
• Rafael Guayta,

  Affiliation Planning and Research Unit, Consell de Collegis Farmacèutics de Catalunya, Girona 64, 08009, Barcelona, Catalonia, Spain

  ⨯
• Sergi Castellví-Bel ,

  Contributed equally to this work with: Sergi Castellví-Bel, Montserrat Andreu

  Affiliation Department of Gastroenterology, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Villarroel 170, 08036, Barcelona, Catalonia, Spain

  ⨯
• Montserrat Andreu ,

  Contributed equally to this work with: Sergi Castellví-Bel, Montserrat Andreu

  * E-mail: mandreu@parcdesalutmar.cat

  Affiliation Department of Gastroenterology, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Pompeu Fabra University, Passeig Marítim 25–29, 08003, Barcelona, Catalonia, Spain

  ⨯
•  [ ... ],
• PROCOLON research group

  ¶All members of the PROCOLON group are listed in the Appendix.

  ⨯
• [ view all ]
• [ view less ]